The half life of efavirenz was reduced in a 38-year-old man with end-stage renal disease Case report 09 February 2013 Pages: 20 - 20
Increased risk of MI with new use of inhaled β-agonists Incidence study 09 February 2013 Pages: 21 - 21
Inhaled corticosteroids: decreased BMD related to cumulative dose Clinical study 09 February 2013 Pages: 21 - 21
Docetaxel [`Taxotere'; Aventis Pharma] has been approved for use in new indications in Japan, News item 09 February 2013 Pages: 22 - 22